Waters Corporation $WAT Shares Sold by OMERS ADMINISTRATION Corp

OMERS ADMINISTRATION Corp decreased its position in Waters Corporation (NYSE:WAT) by 52.0% during the second quarter, Holdings Channel reports. The firm owned 5,113 shares of the medical instruments supplier’s stock after selling 5,539 shares during the quarter. OMERS ADMINISTRATION Corp’s holdings in Waters were worth $1,918,000 at the end of the most recent quarter.

A number of other large investors also recently added to or reduced their stakes in WAT. Anchor Investment Management LLC purchased a new position in shares of Waters during the first quarter worth $27,000. Resources Management Corp CT ADV purchased a new stake in shares of Waters in the 1st quarter valued at $27,000. Zions Bancorporation National Association UT lifted its stake in Waters by 121.2% during the 4th quarter. Zions Bancorporation National Association UT now owns 73 shares of the medical instruments supplier’s stock worth $28,000 after acquiring an additional 40 shares in the last quarter. Vision Retirement LLC acquired a new position in Waters during the 1st quarter worth about $29,000. Finally, Bollard Group LLC purchased a new position in Waters during the 1st quarter valued at about $29,000. 94.01% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Waters

In other news, Director Christopher A. Kuebler sold 3,626 shares of the firm’s stock in a transaction on Thursday, August 6th. The shares were sold at an average price of $397.94, for a total value of $1,442,930.44. Following the sale, the director directly owned 17,808 shares in the company, valued at approximately $7,086,515.52. This trade represents a 16.92% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 0.31% of the company’s stock.

Waters Stock Performance

Shares of Waters stock opened at $415.07 on Thursday. The business has a 50-day simple moving average of $385.08 and a 200-day simple moving average of $347.72. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.29 and a current ratio of 1.86. Waters Corporation has a one year low of $282.77 and a one year high of $421.74. The company has a market cap of $40.78 billion, a PE ratio of 103.51, a P/E/G ratio of 2.41 and a beta of 1.19.

Waters (NYSE:WAT) last issued its earnings results on Tuesday, August 4th. The medical instruments supplier reported $3.05 earnings per share for the quarter, beating the consensus estimate of $3.01 by $0.04. Waters had a net margin of 3.58% and a return on equity of 11.27%. The firm had revenue of $1.65 billion for the quarter, compared to analysts’ expectations of $1.62 billion. During the same quarter last year, the company earned $2.95 earnings per share. The firm’s revenue was up 113.3% compared to the same quarter last year. Waters has set its Q3 2026 guidance at 3.950-4.050 EPS and its FY 2026 guidance at 14.450-14.650 EPS. On average, equities research analysts forecast that Waters Corporation will post 14.56 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on WAT. Piper Sandler started coverage on shares of Waters in a research note on Thursday, June 11th. They set a “neutral” rating and a $400.00 price target on the stock. Morgan Stanley set a $430.00 price objective on shares of Waters in a report on Wednesday, August 5th. Wall Street Zen downgraded shares of Waters from a “buy” rating to a “hold” rating in a research note on Monday, July 20th. The Goldman Sachs Group raised their price target on shares of Waters from $380.00 to $425.00 and gave the company a “buy” rating in a research report on Tuesday, July 14th. Finally, Guggenheim restated a “buy” rating and issued a $440.00 price target on shares of Waters in a research note on Wednesday, July 8th. Three research analysts have rated the stock with a Strong Buy rating, nine have issued a Buy rating and eight have given a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $420.35.

Waters Profile

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.